SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is experiencing a surge in investor interest and bullish momentum following optimistic commentary from the CEO regarding the survival data of its REGAL Phase 3 clinical trial. The community is actively discussing the potential for an imminent short squeeze and institutional accumulation as they wait for the 80th trial event, with many viewing the company's immunotherapy platform as a major, de-risked candidate for future valuation growth.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending as investors and the community spar over the company's financial stability and allegations of corruption surrounding Trump's business dealings. Sentiment remains deeply divided, with critics highlighting the stock's recent performance while supporters maintain loyalty amidst ongoing political controversy.

Cava Group, Inc. is a holding company, which engages in the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. It operates through the following segments: CAVA and CAVA Foods. The CAVA segment includes the operations of all company-owned CAVA restaurants. The CAVA Foods segment includes the production of dips and spreads used in CAVA restaurants as well as sales from the consumer-packaged goods (CPG) business. The company was founded by Brett Schulman, Ike Grigoropoulus, Dimitri Moshovitis, and Theodore Xenohristos in 2010 and is headquartered in Washington, DC.

Cava Group Inc

CAVA Group Inc

CAVA Group is experiencing significant upward momentum driven by a strong earnings beat, raised guidance, and aggressive store expansion plans that have positioned the company as a top performer in the fast-casual sector. The community is actively debating the stock's valuation, with bulls highlighting the company's robust unit growth and competitive moat, while skeptics continue to question its high price-to-earnings multiple.

Keysight Technologies, Inc. engages in the provision of electronic design and test solutions that are used in the design, development, manufacture, installation, deployment, validation, optimization, and secure operation of electronics systems to communications, networking, and electronics industries. It operates through the Communications Solutions Group (CSG) and Electronic Industrial Solutions Group (EISG) segments. The CSG segment serves customers spanning the global commercial communications and aerospace, defense, and government end markets. The EISG segment offers test and measurement solutions across electronic industrial end markets, focusing on applications in the automotive, and energy industry and measurement solutions for semiconductor design and manufacturing, consumer electronics, education, and general electronics manufacturing. The company was founded by William R. Hewlett and David Packard in 1937 and is headquartered in Santa Rosa, CA.

Keysight Technologies Inc

Keysight Technologies is trending following a strong quarterly earnings report that featured a revenue and EPS beat alongside resilient forward guidance, fueling investor optimism despite a challenging macro environment. Community sentiment is mixed as some traders capitalize on the post-earnings volatility while others debate whether the company's AI and data center infrastructure exposure can sustain long-term growth.

COAR is a community-driven meme token on the Solana blockchain built around the theme of oil and energy. The project brings together a growing community of crypto enthusiasts who share an interest in energy-themed digital assets. COAR operates as a fully decentralized token with active trading on Solana decentralized exchanges. The token has a fixed maximum supply of 1 billion units with 6 decimal places, and its mint authority has been permanently revoked, making the supply immutable. The project features a dedicated website at coargov.com with real-time market data integration via DexScreener.

Chinese Oil Asset Reserve

COAR is driving intense debate within the crypto community, with supporters highlighting its unique oil-themed narrative and potential for viral growth, while skeptics warn of volatility and risks associated with potential pump-and-dump mechanics. Traders are actively navigating concerns over exchange visibility and asset security as the token gains traction across social media platforms.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as investors debate the potential implications of a recent FDA workshop and trial status update, while the community heavily scrutinizes significant short interest and stock price volatility. Market sentiment remains polarized, with bullish investors aggressively accumulating shares on dips, citing superior comparative clinical data for ANKTIVA, while others express frustration over persistent price suppression and regulatory uncertainties.

The World Collective Oil Reserve (WCOR) is a public-information program built on the Solana blockchain that mirrors the structure and reporting discipline of national strategic petroleum reserves. It applies established supply-security concepts — including import cover, shock response, emergency release protocols, and transparent stock reporting — to an open, permissionless environment. Data published through the program is drawn from public sources, with approximations clearly identified, and reserve records are maintained on-chain to support auditability, traceability, and independent verification. WCOR is presented as an informational and reference framework rather than a financial product, translating the reporting conventions of traditional strategic inventories into a blockchain-native format that any participant can inspect or cite.

World Collective Oil Reserve

World Collective Oil Reserve is generating significant social media buzz and volatility as investors debate its potential for explosive growth versus risks of it being a speculative pump-and-dump scheme. The community is actively discussing technical chart patterns, seeking guidance on how to navigate complex cross-chain purchasing hurdles, and questioning the legitimacy of viral claims regarding the token's market future.

eXoZymes, Inc. is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV.

eXoZymes Inc.

eXoZymes is trending as investors focus on the company's progress in scaling its proprietary cell-free biomanufacturing platform, particularly following third-party validation of its high-purity NCT production. The community is actively discussing the potential for the company's AI-engineered enzyme technology to serve as a repeatable value engine across nutraceutical and pharmaceutical markets, while simultaneously tracking near-term catalysts like future partnerships and spin-out strategy.

Pattern Group, Inc. engages brands in global ecommerce marketplaces by leveraging proprietary technology and AI. It acquires inventory from brand partners to sell to consumers through online marketplaces, utilizing vast data sets, sophisticated machine learning, and AI models. The company optimizes and automates all levers of ecommerce growth for global brands, enabling full control over advertising, content management, logistics and fulfillment, pricing, forecasting, and customer service. Pattern Group was founded by David Wright and Melanie Alder in 2013 and is headquartered in Lehi, UT.

Pattern Group Inc. - Ordinary Shares - Series A

Pattern Group

Pattern Group is generating significant investor attention following its recent IPO and a blowout earnings report that highlighted strong revenue growth and a new share repurchase program. The community is actively debating the company's transition from a third-party reseller to an AI-enabled e-commerce infrastructure platform, with many investors pointing to its relative strength on red days as a sign of institutional accumulation.

Bright Minds Biosciences, Inc. is a biotechnology company, which engages in the development of therapeutics. The company was founded by Ian B. McDonald and Alan P. Kozikowski on May 31, 2019 and is headquartered in Chicago, IL.

Bright Minds Biosciences Inc

Bright Minds Biosciences is currently trending as investors compare its low-float, biotech pipeline to past explosive runners, sparking heavy social media discussion about potential for a massive rally. Community members are closely tracking the company's clinical milestones and institutional activity, while debating whether current sentiment could lead to a significant upward move similar to historical high-volatility events in the sector.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Trillium Therapeutics Inc. operates as a biopharmaceutical research and development company. It focuses on the immune system and its regulation. The company specializes in the discovery and development of protein therapeutics, such as monoclonal antibodies, secreted proteins, and peptides. It involves in therapeutic areas, including autoimmune disease, cancer, necrotizing enterocolitis, and transplantation. Trillium Therapeutics Inc. was formerly known as Transplantation Technologies Inc. and changed its name in May 2003. The company was founded in 1996 and is based in Toronto, Canada.

TRIL
Trillium Therapeutics

Feed

News

Sentiment

Fundamentals

Info

Compact View

Latest TRIL News

TRILTrillium Therapeutics